Bilirubin Levels Are Negatively Correlated with Adiposity in Obese Men and Women, and Its Catabolized Product, Urobilin, Is Positively Associated with Insulin Resistance
Antioxidants · 11.01.2023 · 12 (1) · 170
DOI: 10.3390/antiox12010170 ↗Kurz gefasst
Fachartikel in der Zeitschrift Antioxidants, online erschienen am 11.01.2023. Verfasst von Zachary A Kipp und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Nutritional Sciences, University of Kentucky, 760 Press Avenue, Healthy Kentucky Research Building, Lexington, KY 4050…. Die Arbeit wurde bisher 49-mal zitiert (Crossref) und nennt 70 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIDDK NIH HHS, NCATS NIH HHS, NIH HHS.
Abstract (Originalsprache)
Bilirubin levels in obese humans and rodents have been shown to be lower than in their lean counterparts. Some studies have proposed that the glucuronyl UGT1A1 enzyme that clears bilirubin from the blood increases in the liver with obesity. UGT1A1 clearance of bilirubin allows more conjugated bilirubin to enter the intestine, where it is catabolized into urobilin, which can be then absorbed via the hepatic portal vein. We hypothesized that when bilirubin levels are decreased, the urobilin increases in the plasma of obese humans, as compared to lean humans. To test this, we measured plasma levels of bilirubin and urobilin, body mass index (BMI), adiposity, blood glucose and insulin, and HOMA IR in a small cohort of obese and lean men and women. We found that bilirubin levels negatively correlated with BMI and adiposity in obese men and women, as compared to their lean counterparts. Contrarily, urobilin levels were positively associated with adiposity and BMI. Only obese women were found to be insulin resistant based on significantly higher HOMA IR, as compared to lean women. The urobilin levels were positively associated with HOMA IR in both groups, but women had a stronger linear correlation. These studies indicate that plasma urobilin levels are associated with obesity and its comorbidities, such as insulin resistance.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Pharmacology and Nutritional Sciences, University of Kentucky, 760 Press Avenue, Healthy Kentucky Research Building, Lexington, KY 40508, USA.
- Department of Internal Medicine, Division of Endocrinology, University of Kentucky, Lexington, KY 40508, USA.
- Barnstable Brown Diabetes Center, University of Kentucky, Lexington, KY 40508, USA.
- Markey Cancer Center, University of Kentucky, Lexington, KY 40508, USA.
ORCID-Profile: Zachary A Kipp, Evelyn A Bates
Förderung
- NIDDK NIH HHS
- NCATS NIH HHS
- NIH HHS
- National Institutes of Health
- Center for Clinical and Translational Science (CCTS)
Zitieren
APA
Kipp, Z. A., Xu, M., Bates, E. A., Lee, W. H., Kern, P. A., & Hinds, T. D. (2023). Bilirubin Levels Are Negatively Correlated with Adiposity in Obese Men and Women, and Its Catabolized Product, Urobilin, Is Positively Associated with Insulin Resistance. Antioxidants, 12(1), 170. https://doi.org/10.3390/antiox12010170
Vancouver
Kipp ZA, Xu M, Bates EA, Lee WH, Kern PA, Hinds TD. Bilirubin Levels Are Negatively Correlated with Adiposity in Obese Men and Women, and Its Catabolized Product, Urobilin, Is Positively Associated with Insulin Resistance. Antioxidants. 2023;12(1):170. doi:10.3390/antiox12010170
BibTeX
@article{Kipp2023,
author = {Kipp, Zachary A and Xu, Mei and Bates, Evelyn A and Lee, Wang-Hsin and Kern, Philip A and Hinds, Terry D},
title = {Bilirubin Levels Are Negatively Correlated with Adiposity in Obese Men and Women, and Its Catabolized Product, Urobilin, Is Positively Associated with Insulin Resistance},
journal = {Antioxidants},
year = {2023},
volume = {12},
number = {1},
pages = {170},
doi = {10.3390/antiox12010170}
}
EUVIMED